Star Scientific, Inc. (NASDAQ:STSI) utilizing alkaloids

Boston, MA 04/05/2013 (wallstreetpr) – Star Scientific, Inc. (NASDAQ:STSI)  is a technology-oriented company, with a view to promote healthy metabolism and lifestyle in the world of fast foods. More recently the company has been concentrating on the anti-inflammatory aspect of one of the alkaloids, anatabine. According to the sources of the company, the research and development efforts on the anatabine alkaloid have positioned them to utilize the technology, and develop a range of non-nicotine dietary supplements and pot related pharmaceutical products with market potentials that could usher in a healthy metabolism and in supporting good nutrition.

Currently trading at $1.37, down by 9.93%. With a total market trade volume of around $251M, the shares of STSI are regularly traded on the stock exchange. A study of the last year’s quoted stocks reveals that the price ranged between $1.26 to as high as $5.05, with an average daily trading of 1.8M shares.

With the growing concern for healthier food supplements, the market is rapidly expanding, unlike before, and Star Scientific is taking full advantage of this fact not only in the United States, but also the globe. The company aims at expanding its horizons soon. And, this is quite evident from the sell-buy analysis of its stocks on NASDAQ for the last several months.

As the research and analysis wing of the company revolves around introducing dietary supplements, which helps to promote “quit smoking”, the market acceptability of their stock has increased to a considerable extent. Exclusive rights on production of low-TSNA dissolvable smokeless tobacco products along with  the use of certain MAO agents in treating neurological conditions have given Star Scientific an edge over its competitors. It may safely be concluded that Star Scientific Inc. has made a firm position on the NASDAQ platform

Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. While reading this article one must assume that we may be compensated for posting this content on our website.

Published by Nicholas Maithya

Nicholas is a Financial Analyst by profession, who enjoys writing about investments, technological developments, business, economics and other financial topics at various financial publications. Join him here on Wallstreetpr.com as he endeavors to deliver to you the latest breaking news on the above mentioned fronts. Contact him by email at nmaithya@gmail.com or follow Nicholas Kitonyi @nmaithyak on Twitter.

Recent Stories

SignUp Now For Our Featured Newsletter